Ji N - Search Results

1

Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.

Wang JQ, Wang B, Lei ZN, Teng QX, Li JY, Zhang W, Ji N, Cai CY, Ma LY, Liu HM, Chen ZS. Wang JQ, et al. Among authors: ji n. Eur J Pharmacol. 2019 Nov 15;863:172611. doi: 10.1016/j.ejphar.2019.172611. Epub 2019 Aug 30. Eur J Pharmacol. 2019. PMID: 31476282

2

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Shukla S, Ambudkar SV, Kong D, Chen ZS. Ji N, et al. Cancer Lett. 2019 Jan;440-441:82-93. doi: 10.1016/j.canlet.2018.10.007. Epub 2018 Oct 10. Cancer Lett. 2019. PMID: 30315846 Free PMC article.

3

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.

Ji N, Yang Y, Cai CY, Lei ZN, Wang JQ, Gupta P, Teng QX, Chen ZS, Kong D, Yang DH. Ji N, et al. Front Pharmacol. 2018 Oct 30;9:1236. doi: 10.3389/fphar.2018.01236. eCollection 2018. Front Pharmacol. 2018. PMID: 30425643 Free PMC article.

4

Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.

Ji N, Yang Y, Lei ZN, Cai CY, Wang JQ, Gupta P, Xian X, Yang DH, Kong D, Chen ZS. Ji N, et al. Biochem Pharmacol. 2018 Dec;158:274-285. doi: 10.1016/j.bcp.2018.10.028. Epub 2018 Oct 26. Biochem Pharmacol. 2018. PMID: 30431011

5

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study.

Ji N, Yang Y, Cai CY, Wang JQ, Lei ZN, Wu ZX, Cui Q, Yang DH, Chen ZS, Kong D. Ji N, et al. Front Oncol. 2019 Jun 18;9:514. doi: 10.3389/fonc.2019.00514. eCollection 2019. Front Oncol. 2019. PMID: 31275850 Free PMC article.

6

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.

Cui Q, Cai CY, Wang JQ, Zhang S, Gupta P, Ji N, Yang Y, Dong X, Yang DH, Chen ZS. Cui Q, et al. Among authors: ji n. Int J Mol Sci. 2019 Aug 22;20(17):4095. doi: 10.3390/ijms20174095. Int J Mol Sci. 2019. PMID: 31443367 Free PMC article.

7

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor.

Yang Y, Ji N, Cai CY, Wang JQ, Lei ZN, Teng QX, Wu ZX, Cui Q, Pan Y, Chen ZS. Yang Y, et al. Among authors: ji n. Cancer Commun (Lond). 2020 Jul;40(7):285-300. doi: 10.1002/cac2.12040. Epub 2020 Jun 11. Cancer Commun (Lond). 2020. PMID: 32525624 Free PMC article.

8

PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study.

Yang Y, Teng QX, Wu ZX, Wang JQ, Lei ZN, Lusvarghi S, Ambudkar SV, Ji N, Chen ZS. Yang Y, et al. Among authors: ji n. Mol Cancer. 2022 Feb 8;21(1):40. doi: 10.1186/s12943-022-01512-0. Mol Cancer. 2022. PMID: 35135547 Free PMC article.

9

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells.

Cui Q, Cai CY, Gao HL, Ren L, Ji N, Gupta P, Yang Y, Shukla S, Ambudkar SV, Yang DH, Chen ZS. Cui Q, et al. Among authors: ji n. Front Oncol. 2019 Apr 25;9:313. doi: 10.3389/fonc.2019.00313. eCollection 2019. Front Oncol. 2019. PMID: 31106148 Free PMC article.

10

Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells.

Wang JQ, Li JY, Teng QX, Lei ZN, Ji N, Cui Q, Zeng L, Pan Y, Yang DH, Chen ZS. Wang JQ, et al. Among authors: ji n. Cancers (Basel). 2020 Feb 18;12(2):466. doi: 10.3390/cancers12020466. Cancers (Basel). 2020. PMID: 32085398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,071 results

Search Page

Filters